104
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

True endpoint reduction by surrogate endpoints

&
Pages 6645-6653 | Received 11 Jan 2016, Accepted 22 Mar 2016, Published online: 28 Aug 2017

References

  • Banerjee, B., Biswas, A. (2011). Estimating treatment difference for binary responses in the presence of surrogate end points. Statistics in Medicine 30:186–196.
  • Banerjee, B., Biswas, A. (2013). Optimal sample proportion for a two-treatment clinical trial in presence of surrogate endpoints. In: Uciski, D., Atkinson, A. C., eds. mODa 10-Advances in Model-Oriented Design and Analysis. Heidelberg:Springer, Vol. 10, pp. 27–34.
  • Banerjee, B., Biswas, A. (2014). Odds ratio for 2 × 2 tables: Mantel-haenszel estimator, profile likelihood and presence of surrogate responses. Journal of Biopharmaceutical Statistics 24:649–659.
  • Banerjee, B., Biswas, A. (2015). Linear increment in efficiency with the inclusion of surrogate endpoint. Statistics and Probability Letters 96:102–108.
  • Begg, C. B., Leung, D. H. Y. (2000). On the use of surrogate endpoints in randomized trials. Journal of the Royal Statistical Society, Series A 163:15–28.
  • Buyse, M., Molenberghs, G. (1998). Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54:1014–1029.
  • Buyse, M., Molenberghs, G., Burzykowski, T., Renard, D., Geys, H. (2000). The validation of surrogate endpoints in meta-analysis of randomized experiments. Biometrics 56:49–67.
  • Chen, S. X., Leung, D. H. Y., Qin, J. (2003). Information recovery in a study with surrogate endpoints. Journal of the American Statistical Association 98:1052–1062.
  • Chen, Y. H. (2000). A robust imputation method for surrogate outcome data. Biometrika 87:711–716.
  • Chuang, C. (1987). Analyzing an pharmaceutical dataset with categorical covariate using monotone scores model. Communications in Statistics Computation and Simulation 16:1–15.
  • Day, N. E., Duffy, S. W. (1996). Trial design based on surrogate endpoints applications to comparison of different breast screening frequencies. Journal of the Royal Statistical Society, Series A 159:49–60.
  • Freedman, L. S., Graubard, B. I., Schatzkin, A. (1992). Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine 11:167–178.
  • Molenberghs, G., Geys, H., Buyse, M. (2001). Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes. Statistics in Medicine 20:3023–3038.
  • Pepe, M. (1992). Inference using surrogate outcome data and validation sample. Biometrika 79:355–365.
  • Prentice, R. L. (1989). Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in Medicine 8:431–440.
  • Reilly, M., Pepe, M. S. (1995). A mean score method for missing and auxiliary covariate data in regression models. Biometrika 82:299–314.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.